Ghosal hematodiaphyseal dysplasia: a rare cause of a myelophthisic anemia.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 20672367)

Published in Pediatr Blood Cancer on December 01, 2010

Authors

Parisa Mazaheri1, Girish Nadkarni, Elizabeth Lowe, Patrick Hines, Melena Vuica, Matthew Griffin, Linda M S Resar

Author Affiliations

1: The Johns Hopkins University School of Medicine, Division of Hematology, Baltimore, Maryland, USA.

Articles by these authors

Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS One (2011) 2.84

Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT. J Clin Oncol (2008) 2.66

Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation (2004) 2.22

Over half of the far-infrared background light comes from galaxies at z >or= 1.2. Nature (2009) 1.71

The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia. Cancer Res (2004) 1.67

A novel method of data analysis for utilization of red blood cell transfusion. Transfusion (2013) 1.52

HMGA2 participates in transformation in human lung cancer. Mol Cancer Res (2008) 1.44

The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies? Cancer Res (2008) 1.43

The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis. Cancer Res (2007) 1.42

HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells. PLoS One (2013) 1.25

HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks. PLoS One (2012) 1.25

HMG-I/Y in human breast cancer cell lines. Breast Cancer Res Treat (2002) 1.23

HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis. BMC Genomics (2011) 1.19

High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase-2 expression in prostate cancer cells. Prostate (2004) 1.18

Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer. Mol Cancer Res (2009) 1.15

HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells. PLoS One (2012) 1.15

HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma. Mod Pathol (2009) 1.14

Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation. Oncogene (2004) 1.11

Flavopiridol induces BCL-2 expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia. Leuk Lymphoma (2011) 1.07

High mobility group A1 and cancer: potential biomarker and therapeutic target. Histol Histopathol (2012) 1.05

One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India. AIDS Res Hum Retroviruses (2010) 1.01

HMG-I/Y is a c-Jun/activator protein-1 target gene and is necessary for c-Jun-induced anchorage-independent growth in Rat1a cells. Mol Cancer Res (2004) 1.00

Cyclooxygenase inhibitors block uterine tumorigenesis in HMGA1a transgenic mice and human xenografts. Mol Cancer Ther (2008) 0.99

Molecular evidence of injury and inflammation in normal and fibrotic renal allografts one year posttransplant. Transplantation (2007) 0.96

Concentrations of B vitamins and homocysteine in children with sickle cell anemia. South Med J (2004) 0.93

Preventing early childhood caries: lessons from the field. Pediatr Dent (2007) 0.87

Risk-adjusted clinical outcomes in patients enrolled in a bloodless program. Transfusion (2014) 0.87

Hitting the bull's eye: targeting HMGA1 in cancer stem cells. Expert Rev Anticancer Ther (2014) 0.86

Blood pressure evaluation among older living kidney donors. J Am Soc Nephrol (2003) 0.86

AKNA: another AT-hook transcription factor "hooking-up" with inflammation. Cell Res (2011) 0.85

HMGA1 overexpression correlates with relapse in childhood B-lineage acute lymphoblastic leukemia. Leuk Lymphoma (2013) 0.84

Pulsed-dosing with oral sodium phenylbutyrate increases hemoglobin F in a patient with sickle cell anemia. Pediatr Blood Cancer (2008) 0.84

The high mobility group A1 molecular switch: turning on cancer - can we turn it off? Expert Opin Ther Targets (2014) 0.84

HMGA1 drives metabolic reprogramming of intestinal epithelium during hyperproliferation, polyposis, and colorectal carcinogenesis. J Proteome Res (2015) 0.82

The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma. Pancreatology (2012) 0.82

The Efficacy and Utility of Acute Normovolemic Hemodilution. Anesth Analg (2015) 0.80

Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia. J Clin Endocrinol Metab (2009) 0.78

Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study. Inflamm Bowel Dis (2017) 0.78

Nanoparticle delivery of inhibitory signal transducer and activator of transcription 3 G-quartet oligonucleotides blocks tumor growth in HMGA1 transgenic model of T-cell leukemia. Leuk Lymphoma (2013) 0.77

Characterizing metabolic changes in human colorectal cancer. Anal Bioanal Chem (2015) 0.77

Patent foramen ovale in patients with sickle cell disease and stroke: case presentations and review of the literature. Case Rep Hematol (2013) 0.76

Dexmedetomidine use in the setting of cocaine-induced hypertensive emergency and aortic dissection: a novel indication. Case Rep Med (2011) 0.75

Haemodynamic and pulse wave responses to intravenous infusions of angiotensin II during chronic telmisartan therapy in normal volunteers. J Renin Angiotensin Aldosterone Syst (2003) 0.75

IBRUTinib: BRUTe force against bortezomib-resistant myeloma cells. Cell Cycle (2015) 0.75

Low dose, oral epsilon aminocaproic acid for renal papillary necrosis and massive hemorrhage in hemoglobin SC disease. Pediatr Blood Cancer (2010) 0.75

Living-donor kidney transplantation at Mayo Clinic--Rochester. Clin Transpl (2002) 0.75

Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study. Inflamm Bowel Dis (2017) 0.75

The Irish Kidney Gene Project--Prevalence of Family History in Patients with Kidney Disease in Ireland. Nephron (2015) 0.75

Increase in systemic blood pressure during intra-arterial PD123319 infusion: evidence for functional expression of angiotensin type 2 receptors in normal volunteers. Blood Press (2004) 0.75

Thermal illuminators for far-infrared and submillimeter astronomical instruments. Appl Opt (2005) 0.75

Family-witnessed resuscitation: bereavement outcomes in an urban environment. J Palliat Med (2011) 0.75